Abstract
Given the disproportionate burden of childhood diarrhea deaths in Nigeria, this study assessed the prevalence and predictors of the disease and the uptake of ORS and zinc supplementation as treatments in a population-based national survey. Cross-sectional data from the 2018 Nigeria Demographic Health Survey were used. A log-Poisson regression was used to estimate the relative risks (RR) for the individual-level predictors of childhood diarrhea and the uptake of ORS and zinc treatments. A total of 30,713 children under 5 years of age were included in the survey. The period prevalence of reported diarrhea in the last two weeks was 12.9% (95% CI: 12.5%, 13.3%). Among the children with diarrhea, the proportion who received ORS was 39.7% (95% CI: 38.2%, 41.3%), while 29.1% of them received zinc supplements (95% CI: 27.7%, 30.5%), and 21.8% of them received both the ORS and zinc treatments as recommended. Children under 6 months of age with diarrhea had a significantly lower likelihood of being given ORS or zinc when they were compared to the older children. The institutional delivery of them, maternal employment, and improved water sources were also independent predictors of the uptake of ORS and zinc treatments for diarrhea (p-values < 0.05). Interventions to prevent childhood diarrhea and improve the coverage of ORS and zinc treatments may reduce the large burden of childhood diarrhea deaths in Nigeria.
1. Introduction
Despite there being remarkable reductions in them during the past two decades, 500,000 deaths attributable to diarrhea continue to occur each year among children that are less than 5 years of age [1,2]. The Sustainable Development Goals (SDGs) call on all countries to reduce their under-five mortality to less than 25 per 1000 live births by 2030 [1]. Nigeria currently has an under-five mortality of 114 deaths per 1000 live births [3], and it is estimated that 16% of the remaining child deaths are attributable to diarrhea [4]. In Nigeria, the diarrheal disease was only second to neonatal disorders among the main causes of childhood death in 2019, while other major causes of child death include lower respiratory infections, malaria, and meningitis [4]. Nigeria has less than 5% of the world’s population of children that are under five years old [5], while approximately one-quarter of the global childhood diarrhea deaths occur in the country (~132,000) [2]. Therefore, Nigeria faces a disproportionately large burden of childhood diarrhea deaths.
Diarrhea results in loss of water and electrolytes (e.g., sodium, chloride, potassium), which—if not replaced—can lead to dehydration and child death. The World Health Organization (WHO) and the Government of Nigeria recommend that childhood diarrhea is treated with an oral rehydration solution (ORS) and a zinc supplementation [6,7]. The ORS and zinc supplementation are simple and effective interventions; ORS is estimated to reduce the risk of diarrhea mortality by 93%, and the zinc supplementation reduces the duration of diarrhea, stool output, and risk of persistent diarrhea [8,9].
Given the disproportionate burden of childhood diarrhea deaths in Nigeria and the effectiveness of the ORS and zinc supplementations, we examined the population- and individual-level predictors of diarrhea prevalence and the uptake of ORS and zinc treatments. These population- and individual-level predictors may explain the variation in update of these interventions across Nigeria. Based on a literature review, we examined the child, maternal, and household factors that were hypothesized to be associated with diarrhea incidence or treatment uptake. These results are intended to inform the design of the interventions and public health programs to prevent diarrhea and increase the uptake of ORS and zinc supplementations for the treatment of diarrhea among children that are under 5 years of age.
2. Materials and Methods
2.1. Study Design
The study used data from the 2018 Nigeria Demographic Health Survey (NDHS) [10]. The 2018 NDHS is a nationally representative cross-sectional household survey that collected data on demographic and health indicators from all 36 states and the Federal Capital Territory. The NDHS used a stratified two-stage cluster sampling design that was stratified by the states and Federal Capital Territory, which were further separated into the urban and rural areas. A total of 1400 enumeration areas (EAs) were selected with probability proportional to size sampling (PPS), and 30 households were randomly selected in each cluster. All of the women aged 15–49 and a subsample of men aged 15–59 were interviewed for the survey in the selected households. The complete details of the sampling methods are found in the 2018 NDHS report. We obtained the approval of the DHS program to use the de-identified and publicly available dataset for this study.
2.2. Study Population
The analytic samples for this study were: (i) all of the children who were under 5 years of age that participated in the 2018 NDHS (n = 30,713) and (ii) the subsample of children that had diarrhea which had been reported by mothers/caregivers during the two weeks prior to the survey (n = 3956).
2.3. Outcomes
The mothers/caregivers were asked whether their child had at least one diarrhea episode during the two weeks prior to the survey visit. Among those that reported diarrhea, the mothers/caregivers were asked if the child received ORS or zinc supplementation as a treatment. ORS was considered to have been given if the mother/caregiver reported the child was ‘given oral rehydration’ or ‘given recommended home solution’.
There were four outcomes which were examined in this study. The first outcome was a maternal report of diarrhea during the prior two weeks among the children under age five (yes/no). Then, among this group, three additional outcomes were considered: whether an ORS treatment was given (yes/no), whether a zinc treatment was given (yes/no), and if both the ORS and zinc treatments (ORS) were given as recommended (yes/no).
2.4. Explanatory Variables
The explanatory variables that were included in the 2018 NDHS were selected before the analysis based on a literature review of child, maternal, and household characteristics that may be associated with diarrhea incidence or treatment. The characteristics of the child included their: age (<6 months, 6–11, 12–23, 24–35, 36–47, or 48–59 months), sex, birth order (first, second and third, fourth and fifth, or sixth and above), whether the child lived with the mother, and the place of delivery (institutional or non-institutional). The maternal/caregiver characteristics were their: age (<20, 20–34, or 35–49 years), education level (no formal education, primary, secondary, and higher education), marital status (never in a union, married/living with a partner, and widowed/divorced/separated), whether she was working, religion (Catholic, other Christian denomination, Islam, Traditionalist, and Others), and ethnicity. The household characteristics included: the region of residence, whether it was an urban/rural residence, the sex of the household head, the source of the drinking water (improved or unimproved), the toilet facility (improved or unimproved), the presence of water at hand washing place, whether there was soap or detergent at the hand washing place, and which quintile the household was in according to their wealth. The household wealth quintiles were directly coded from the 2018 NDHS and were calculated based on ownership of materials and the household characteristics using a principal component analysis. Improved and unimproved drinking water and toilet facilities were defined using the WHO/UNICEF Joint Monitoring Program (JMP) definitions.
2.5. Statistical Analysis
All of the analyses accounted for the design of the 2018 NDHS including the stratification and cluster sampling. Firstly, the descriptive statistics of children under 5 years old, their mothers, and the households were assessed. Secondly, we calculated the proportion of them that had diarrhea and received the ORS and zinc treatment for diarrhea, nationally, for the six geopolitical zones and for 36 Nigerian States and the Federal Capital Territory. Then, we examined the child, maternal and household predictors of childhood diarrhea in univariable and multivariable log-Poisson regression models to estimate the relative risks. The log-Poisson models were selected due to convergence issues for multivariable models; however, the log-Poisson models provided consistent, but not fully efficient estimates of the relative risk and its confidence intervals [11]. Fourthly, we determined the proportion of children with diarrhea that were reported to have received ORS, zinc, and ORS and zinc treatments, and then, we used the univariable and multivariable log-Poisson regression models to estimate the relative risks for the child, maternal and household characteristics [11]. All of the analyses were conducted in Stata version 12 [12].
3. Results
A total of 30,713 children under 5 years of age that participated in the 2018 NDHS were included in the analysis. The characteristics of households, mothers, and children are presented in Table 1. The child sex distribution in the overall sample was balanced; 50.6% of them were male and 49.4% of them were female, and only 40.5% of the children were delivered in institutional facilities. The majority (70.3%) of the mothers were 20–35 years of age, and approximately 95% of them were either married or cohabitated with partners as at the time of the survey.
Table 1.
Child, maternal, and household characteristics of children under 5 years of age included in the 2018 Nigeria DHS (N = 30,713) and characteristics of the sub-sample of children under 5 years of age for whom mothers/caregivers reported diarrhea during the 2 weeks prior the survey (N = 3956).
3.1. Childhood Diarrhea
A total of 3956 children had mothers/caregivers who reported diarrhea during the 2 weeks prior to the survey. The characteristics of the subsample of children with diarrhea are also presented in Table 1. In the subsample, a similar sex distribution was observed, 50.9% of them were male and 49.1% of them were female, and only 29.8% of the children with diarrhea were delivered in an institutional facility.
The national period prevalence of childhood diarrhea among children under 5 years of age was 12.9% (95% CI: 12.5%, 13.3%). The period prevalence varied widely by states, ranging from 0.9% in Ogun to 35% in Gombe (Figure 1). The regional diarrhea prevalence ranged from 5.2% in the southwest to 24.6% in the northeast region (Supplementary Table S1 and Table A1). The table also shows the prevalence of diarrhea by the child, maternal, and household characteristics with childhood diarrhea.
Figure 1.
Period prevalence of diarrhea during the two weeks prior to the survey among children under 5 years of age by state compared to the national average of 12.9%.
Table 2 shows the results of the univariable and multivariable models that examined risk factors for diarrhea. In the multivariable models, the risk of diarrhea differed by child age; children aged 6–11 months (RR = 2.02: 95% CI: 1.77, 2.32), 12–23 months (RR = 2.04: 95% CI: 1.80, 2.32) and 24–35 months (RR = 1.39: 95% CI: 1.20, 1.58) had an increased risk of diarrhea when they were compared to children that were 0–6 months of age. In addition, children who had a birth order of six or greater had greater a risk of diarrhea when they were compared to firstborns (p-Value: 0.006). In terms of the maternal factors, maternal age, maternal education, and maternal employment status were associated with reported diarrhea (p-Values < 0.05). As for the household factors, region of residence and household wealth quintile were strongly associated with the risk of diarrhea. The children in the highest wealth quintile had 65% lower risk of having diarrhea (RR = 0.35: 95% CI: 0.31, 0.40) when they were compared to the poorest wealth quintile. Some religious and ethnic groups also had a greater risk of diarrhea in the multivariable models. There was no relationship between water source or sanitation and the risk of reported diarrhea.
Table 2.
Factors associated with childhood diarrhea during the two weeks prior to the survey in the 2018 Nigeria DHS (N = 30,713).
3.2. Uptake of ORS and Zinc Supplements for Treatment of Childhood Diarrhea
Among the children that had diarrhea, 39.7% of them were reported to have received the ORS treatment (95% CI: 38.2%, 41.3%), 29.1% of them received the zinc treatment (95% CI: 27.7%, 30.5%), and 21.8% of them (95% CI: 20.5%, 23.1%) were reported to have received the ORS and zinc treatments as recommended. The distribution of the use of the ORS or zinc and both the ORS and zinc treatments varied by state and region as shown in Supplementary Figure S1 and Table A3, Figure 2 and Table A2, and Figure 3, respectively.
Figure 2.
Percentage of children with diarrhea during the 2 weeks prior to the survey that were reported to have received zinc supplements by state compared to the national average of 29.1%.
Figure 3.
Percentage of children with diarrhea during the 2 weeks prior to the survey that were reported to have received oral rehydration solution (ORS) and zinc supplements by state compared to the national average of 21.8%.
Supplementary Table S2 shows the percentage of children who received the ORS or zinc and ORS and zinc treatments against the child, maternal, and household characteristics. The univariable and multivariable models that assessed the factors associated with uptake of the ORS or zinc and ORS and zinc treatments are presented in Supplementary Table S3 and Table 3, respectively. In the multivariable models, the children who were 0–6 months of age had a lower zinc and ORS treatment uptake when they were compared to the categories of children who were 6–35 months of age (p-values < 0.05), while the children who were delivered in a facility had higher rate of ORS and zinc treatment uptake (p-Values < 0.05).
Table 3.
Multivariable relative risks for reported receipt of oral rehydration solution (ORS), zinc and ORS and zinc treatment for children with diarrhea during the 2 weeks prior to the survey in the 2018 Nigeria DHS (N = 3956).
In terms of maternal factors, the mother not working and them having a maternal age of over 35 were associated with a lower uptake of the ORS treatment (p-values < 0.05), while no maternal factors were identified to be associated with the zinc treatment. As for the household factors, an improved water source was associated with an increased uptake of the ORS or zinc and both the ORS and zinc treatments. Some religions, ethnic groups and regions also had greater uptake of the ORS or zinc treatments after an adjustment for other factors. Compared to other regions, both Northwest and Southwest areas appear to have the highest likelihood of utilization of all of the childhood diarrhea recommended treatment methods.
4. Discussion
We found a national diarrhea 2-week period prevalence of 12.9% among children under 5 years of age in Nigeria. The risk of reported diarrhea was found to vary considerably between the states and regions. It is likely that this variation is due to a combination of population- and individual-level factors. We also identified several child, maternal, and household characteristics associated with reported diarrhea including child age, the birth order, maternal age, maternal education, and maternal employment status, the region of residence, and the household wealth quintile. We also found that the standard treatment for acute diarrhea was low with only 39.7%, 29.1%, and 21.8% of the children with diarrhea reporting to have received the ORS, zinc, and ORS and zinc treatments, respectively. The ORS and zinc treatment uptake varied by state and region, and we identified that several child, maternal, and household factors are associated with the receipt of each intervention, notably, children who were 0–6 months old and children in households with unimproved water sources had a lower uptake of both of the diarrhea treatment interventions.
The childhood diarrhea period prevalence in the 2018 NDHS in this study is slightly greater than the national period prevalence of 10.0%, which was reported in the 2013 NDHS [10]. This may be due to there being a minimal difference in the uptake of prevention and diarrhea treatment interventions over time. As a result, there is a clear indication of an urgent need to strengthen the existing national control and preventive efforts against childhood diarrhea as well as to identify new initiatives and programs to reduce the incidence of the diarrhea. Nevertheless, it is important to note that the prevalence of childhood diarrhea in our study is lower when it is compared to those which are seen in other countries in sub-Saharan Africa: Ghana (17%) [13], Kenya (15%) [14], and Uganda (20%) [15].
We found that the child, maternal, and household factors were associated with reported childhood diarrhea. We found reported childhood diarrhea was more prevalent among the children who were 6–11 and 12–23 months old when they were compared to the children who were under six months old. This finding is consistent with the distribution of diarrhea risk that has been reported in previous studies [13,14]. The low risk of childhood diarrhea that is associated with infants that are under 6 months old, among other reasons, may be largely attributed to the effect of exclusive breastfeeding which is known to reduce the incidence of diarrhea in this age group [16]. Moreover, older children exhibit greater mobility, and therefore, may have increased environmental risks for diarrhea [14]. However, in our study, the diarrhea incidence considerably declined after 35 months, and it was the lowest among the children who were 48–59 months old. Older children may have developed stronger immunity against routine childhood diseases if they were compared to the younger children [17,18,19]. We also found that children with a birth order of six or greater had a higher risk of diarrhea, and this likely reflects that there are a larger number of children in the household which may increase their exposure to diarrhea pathogens as well as there being potential differences in their care practices. We also found that children from young mothers who were under 20 years of age had an increased risk of diarrhea which is in line with previous studies in Uganda and Tanzania [15,20,21]. We did not find a significant association between the source of drinking water, toilet facility, or having water or soap in hand washing places with the diarrhea prevalence. A rational explanation for the observed non-significant association is that its availability may not necessarily translate to its usage. Previous cross-sectional studies have also failed to identify an association between childhood diarrhea and sanitation facilities, water sources, or handwashing facilities [14,22].
Our study also observed the sub-optimal utilization of ORS treatments with only one in five children with diarrhea having reported to have received the ORS and zinc treatments as recommended. However, it is important to note we also found considerable variation across the thirty-six states and the Federal capital territory of Abuja. A contributor to the variation may be that there are different diarrhea treatment programs and projects between the regions. For example, a program that included policy revision and partner coordination, market-shaping to improve its availability, provider training and mentoring, and caregiver demand generation was found to significantly increase the ORS and zinc treatment coverage in eight states of Nigeria [23]. Therefore, there is an urgent need for the integration of these programs to promote uptake of these diarrhea treatment interventions across the country. Nevertheless, the utilization of ORS and zinc treatments that were recorded in our study are higher than 18.9 and 14.8%, respectively, than those that were found in Sudan [24], but they are similar to the 30% coverage of the ORS treatment in Ethiopia [25], as well as being slightly higher than the 21.5% coverage of the zinc treatment in the East African countries [26]. As a result, this shows that the zinc and ORS treatment coverage remains a challenge in sub-Saharan Africa, and there are differences between the countries in the region as well as significant variation within the country context as shown in our study.
We found individual-level child, maternal, and household predictors of ORS and zinc treatment coverage. Previous studies in Nigeria had associated this low coverage with a poor knowledge of its benefits and preparation in the case of the ORS treatment [27,28,29]. Our study also found a significant association between the child’s age and the uptake of the ORS and zinc treatments during an episode of diarrhea. The coverage of the ORS and zinc treatments were particularly low for the infants that were 0–6 months of age, a group that may also face a greater risk of diarrhea mortality. We hypothesize this is related to exclusive breastfeeding promotion and potential confusion from mothers and health workers that ORS treatments and vitamins can be given, and they are not considered to be mixed with feeding [30,31]. Our findings are consistent with a study that was conducted in Sudan, which also found an increased likelihood of uptake of ORS treatments in older children [24]. We also found a significant association between the uptake of the ORS, zinc, and ORS plus zinc treatments with having an improved source of drinking water. This emphasizes the importance of the availability of clean water for the preparation of the ORS and oral zinc treatments. Researchers have advocated for the production of commercial 1-L water packages as part of the ORS preparation [28]. We found that the children who were born in an institutional facility were more likely to be given an ORS treatment. We think this is likely a proxy for the access and preference for services in the health care system. A study that was conducted in Ethiopia also reported a significant increase in the likelihood of the uptake of an ORS treatment with prenatal clinic attendance [25]. We found no association between maternal education with the ORS and zinc treatment coverage, which is aligned with studies that were conducted in Sudan and Ethiopia [24,26]. However, we did not find a significant association between the rural/urban residence, which contrasts with a study in Sudan [24], where the children in rural settings were less likely to be given the ORS or zinc treatments when they were compared to the urban children. As a result, we found a diverse set of factors associated with the use of the ORS and zinc treatments, and it will be important to consider the local context in the design of interventions that seek to improve the ORS and zinc treatment coverage.
Our study has several limitations. Firstly, we relied on the occurrence of maternally reported diarrhea as well as zinc and ORS treatments. As a result, the occurrence of a misclassification is possible, and we hypothesize that the mothers may have overreported the occurrence of the zinc and ORS treatments due to its social desirability so the true coverage of these interventions may in fact be lower. In addition, our study was cross-sectional, and as a result, causality cannot be implied. In addition, we did not examine the relationship of the characteristics of the fathers or adult males in the household with diarrhea prevalence and treatment uptake. Last, our study was conducted in Nigeria, and so, the findings may not be generalizable to other settings in sub-Saharan Africa.
5. Conclusions
The childhood diarrhea prevalence remains high while the ORS and zinc treatment coverages are low in Nigeria with there being a large variation across the 36 states and the Federal capital territory. Based on our analysis, these differences in the coverages are likely due to a combination of population- and individual-level factors. We also found a diverse set of child, maternal, and household factors that are associated with diarrhea and the ORS and zinc treatment coverages. Programs should consider these multiple determinants to design interventions. Interventions are urgently needed to reduce the diarrhea incidence, improve the ORS and zinc treatment coverage to reduce the number of diarrhea deaths, and support Nigeria to achieve the Sustainable Development Goals on child mortality by 2030.
Supplementary Materials
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/children9111722/s1, Supplementary Table S1: Period prevalence of diarrhea during the 2 weeks prior to the survey among children under 5 years of age in the 2018 NDHS (N = 30,713); Supplementary Table S2: Proportion of children under 5 years of age with diarrhea for whom mothers/caregivers reported the child received ORS, zinc and ORS and zinc in the 2018 NDHS (N = 3956); Supplementary Figure S1: Percentage of children with diarrhea during the 2 weeks prior to the survey that were reported to have received oral rehydration solution (ORS) by state in the 2018 NDHS; Supplementary Table S3: Univariable regression models to estimate the likelihood of uptake of Zinc and ORS by under 5 children, maternal and household characteristics during episode of childhood diarrhea in the NDHS 2018.
Author Contributions
B.E.E. conceived the research question. B.E.E. and C.R.S. designed the study. B.E.E. acquired the data, performed statistical analysis and interpreted the results with support from C.R.S. B.E.E. prepared the first draft of the article and all the authors; O.K., C.R.S. and B.E.E. reviewed it critically and made significant contributions to the manuscript. All authors have read and agreed to the published version of the manuscript.
Funding
BEE was supported by the Takemi Fellowship in International Health of the Harvard T.H School of Public Health, Harvard University.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki, and received a non-human subjects research determination from the Harvard T.H. Chan School of Public Health (Protocol code IRB21-1680, 16 December 2021).
Informed Consent Statement
Not applicable.
Data Availability Statement
The data that support the findings of this study are openly available from the DHS program at https://dhsprogram.com/data (accessed on 19 October 2021).
Acknowledgments
We sincerely appreciate the MEASURE DHS program for granting us official permission to use the dataset for this study.
Conflicts of Interest
The authors declare no conflict of interest.
Appendix A
Table A1.
Point and interval estimates of children under 5 that had diarrhea episode 2 weeks before the survey by Regions and States.
Table A1.
Point and interval estimates of children under 5 that had diarrhea episode 2 weeks before the survey by Regions and States.
| Region/State | Percent of Children under 5 That Had Diarrhea Episode 2 Weeks before the Survey (95% CI) |
|---|---|
| North Central | 11.4 (10.4,12.4) |
| Benue | 11.2 (9.1, 13.6) |
| Kogi | 6.6 (4.8, 9.1) |
| Kwara | 8.3 (6.0, 11.4) |
| Nasarawa | 5.7 (3.9, 8.3) |
| Niger | 16.3 (14.1, 18.8) |
| Plateau | 13.3 (10.9, 16.1) |
| FCT | 8.2 (6.2, 10.7) |
| Northeast | 24.6 (23.4, 25.9) |
| Adamawa | 10.7 (8.3, 13.6) |
| Bauchi | 34.1 (31.5, 36.9) |
| Borno | 8.9 (7.0, 11.2) |
| Gombe | 35.0 (32.1, 38.0) |
| Taraba | 23.1 (20.5, 26.0) |
| Yobe | 33.4 (30.0, 37.0) |
| Northwest | 13.8 (13.0, 14.6) |
| Kaduna | 11.8 (9.9, 14.0) |
| Kano | 17.7 (15.9, 19.6) |
| Katsina | 13.7 (11.9, 15.7) |
| Jigawa | 19.1 (16.9, 21.4) |
| Kebbi | 9.6 (8.0, 11.6) |
| Sokoto | 18.5 (15.9, 21.3) |
| Zamfara | 3.9 (2.7, 5.5) |
| Southeast | 6.1 (5.3.7.0) |
| Anambra | 3.1 (2.2, 4.5) |
| Abia | 3.0 (1.9, 4.7) |
| Ebonyi | 10.5 (8.6, 12.8) |
| Enugu | 4.1 (2.6, 6.2) |
| Imo | 9.1 (6.9, 11.8) |
| South | 6.1 (5.1, 7.2) |
| Akwa Ibom | 8.1 (6.0, 11.0) |
| Bayelsa | 1.2 (0.6, 2.6) |
| Delta | 3.8 (2.2, 6.5) |
| Edo | 4.3 (2.7, 7.0) |
| Cross River | 4.5 (2.7, 7.4) |
| Rivers | 9.0 (6.9, 11.7) |
| Southwest | 5.2 (4.4, 6.1) |
| Ogun | 0.9 (0.3, 2.3) |
| Ondo | 6.9 (5.0, 9.4) |
| Oyo | 5.7 (3.9, 8.3) |
| Osun | 9.0 (6.6, 12.1) |
| Lagos | 3.9 (2.8, 5.6) |
| Ekiti | 9.3 (6.2, 13.7) |
| Nigeria | 12.9 (12.5, 13.5) |
Table A2.
Percentage of children with diarrhea during the 2 weeks prior to the survey that were reported to have received zinc in the 2018 NDH by Regions and States.
Table A2.
Percentage of children with diarrhea during the 2 weeks prior to the survey that were reported to have received zinc in the 2018 NDH by Regions and States.
| Region/State | Percent of Children Given Zinc Supplement at Episode of Diarrhea (95% CI) |
|---|---|
| North Central | 22.9 (19.3, 27.1) |
| Benue | 33.6 (24.5, 44.1) |
| Kogi | 7.9 (2.5, 22.5) |
| Kwara | 6.6 (2.1, 18.7) |
| Nasarawa | 75.1 (55.8, 87.8) |
| Niger | 20.3 (14.8, 27.2) |
| Plateau | 9.3 (4.5, 18.1) |
| FCT | 30.0 (18.0, 45.6) |
| Northeast | 22.0 (19.5, 24.6) |
| Adamawa | 24.9 (14.9, 38.6) |
| Bauchi | 20.6 (17.0, 24.8) |
| Borno | 44.2 (32.4, 56.7) |
| Gombe | 21.4 (17.4, 26.2) |
| Taraba | 2.9 (13.9, 6.2) |
| Yobe | 25.3 (19.8, 31.7) |
| Northwest | 41.9 (38.9, 44.9) |
| Kaduna | 20.3 (13.2, 29.8) |
| Kano | 45.6 (40.0, 51.3) |
| Katsina | 44.5 (37.3, 51.9) |
| Jigawa | 60.1 (53.6, 66.3) |
| Kebbi | 38.4 (29.2, 48.4) |
| Sokoto | 36.9 (29.5, 45.0) |
| Zamfara | 30.4 (15.8, 50.4) |
| Southeast | 27.5 (21.8, 34.1) |
| Anambra | 58.0 (39.2, 74.8) |
| Abia | 35.5 (17.5, 58.8) |
| Ebonyi | 25.3 (17.5, 35.2) |
| Enugu | 6.4 (15.4, 23.2) |
| Imo | 18.6 (10.1, 31.9) |
| South | 32.7 (25.4, 41.1) |
| Akwa Ibom | 17.4 (7.5, 35.4) |
| Bayelsa | 77.4 (39.7, 94.7) |
| Delta | 56.4 (29.8, 79.7) |
| Edo | 19.5 (7.7, 41.2) |
| Cross River | 57.1 (31.2, 79.6) |
| Rivers | 30.6 (20.0, 43.6) |
| Southwest | 35.1 (27.4, 43.6) |
| Ogun | 56.3 (15.2, 90.3) |
| Ondo | 7.3 (1.8, 24.6) |
| Oyo | 47.2 (29.1, 66.0) |
| Osun | 21.7 (11.1, 38.1) |
| Lagos | 37.0 (22.1, 54.9) |
| Ekiti | 54.1 (34.0, 72.9) |
| Nigeria | 29.1 (27.7, 30.5) |
Table A3.
Percentage of children with diarrhea during the 2 weeks prior to the survey that were reported to have received oral rehydration solution (ORS) in the 2018 NDH by Regions and States.
Table A3.
Percentage of children with diarrhea during the 2 weeks prior to the survey that were reported to have received oral rehydration solution (ORS) in the 2018 NDH by Regions and States.
| Region/State | Percent of Children Given ORS at Episode of Diarrhea (95% CI) |
|---|---|
| North Central | 40.8 (36.2, 45.5) |
| Benue | 45.6 (35.3, 56.3) |
| Kogi | 37.4 (23.2, 54.2) |
| Kwara | 35.3 (20.6, 53.5) |
| Nasarawa | 82.9 (61.9, 93.5) |
| Niger | 42.0 (34.6, 49.8) |
| Plateau | 18.4 (11.2, 28.5) |
| FCT | 48.1 (34.2, 62.2) |
| Northeast | 38.2 (35.3, 41.1) |
| Adamawa | 42.1 (30.2, 55.1) |
| Bauchi | 36.5 (31.9, 41.3) |
| Borno | 82.7 (72.8, 89.5) |
| Gombe | 26.1 (21.8, 31.0) |
| Taraba | 10.0 (6.6, 14.9) |
| Yobe | 46.2 (39.7, 52.9) |
| Northwest | 43.4 (40.4, 46.4) |
| Kaduna | 5.1 (2.8, 8.9) |
| Kano | 55.1 (49.3, 60.7) |
| Katsina | 40.4 (33.4, 47.9) |
| Jigawa | 63.9 (57.4, 69.9) |
| Kebbi | 41.9 (32.6, 51.8) |
| Sokoto | 47.9 (40.0, 60.0) |
| Zamfara | 33.2 (18.0, 53.0) |
| Southeast | 44.9 (38.2, 51.8) |
| Anambra | 68.9 (48.9, 83.7) |
| Abia | 40.6 (20.8, 63.9) |
| Ebonyi | 41.5 (31.6, 52.2) |
| Enugu | 26.1 (11.9, 48.1) |
| Imo | 43.4 (30.9, 56.8) |
| South | 44.6 (36.3, 53.1) |
| Akwa Ibom | 30.8 (17.8, 47.9) |
| Bayelsa | 77.4 (39.7, 94.7) |
| Delta | 59.2 (32.2, 81.6) |
| Edo | 48.5 (26.1, 71.5) |
| Cross River | 66.1 (41.1, 84.5) |
| Rivers | 41.7 (29.3, 55.2) |
| Southwest | 52.9 (44.7, 60.9) |
| Ogun | 80.7 (30.2, 97.6) |
| Ondo | 35.4 (21.5, 52.4) |
| Oyo | 55.2 (35.9, 72.9) |
| Osun | 47.2 (32.1, 62.8) |
| Lagos | 65.2 (47.8, 79.3) |
| Ekiti | 44.6 (25.6, 65.4) |
| Nigeria | 39.7 (38.2, 41.3) |
References
- Paulson, K.R.; Kamath, A.M.; Alam, T.; Bienhoff, K.; Abady, G.G.; Abbas, J.; Abbasi-Kangevari, M.; Abbastabar, H.; Abd-Allah, F.; Abd-Elsalam, S.M.; et al. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: All-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. Lancet 2021, 398, 870–905. [Google Scholar] [CrossRef]
- GBD Results Tool. Available online: https://vizhub.healthdata.org/gbd-results/ (accessed on 24 April 2022).
- Global Health Data Exchange. GBD Results Tool GHDx. Available online: https://ghdx.healthdata.org/gbd-2019 (accessed on 24 April 2022).
- Jiwok, J.C.; Adebowale, A.S.; Wilson, I.; Kancherla, V.; Umeokonkwo, C.D. Patterns of diarrhoeal disease among under-five children in Plateau State, Nigeria, 2013–2017. BMC Public Health 2021, 21, 2086. [Google Scholar] [CrossRef] [PubMed]
- World Population Prospect 2019. Mortality rate, under-5 (per 1000 live births)—Nigeria Data (worldbank.org). Available online: https://data.worldbank.org/indicator/SH.DYN.MORT?locations=NG (accessed on 25 April 2022).
- UNICEF. Diarrhea. Available online: https://data.unicef.org/topic/child-health/diarrhoeal-disease (accessed on 23 February 2022).
- WHO. Diarrhea. Available online: https://www.who.int/health-topics/diarrhoea (accessed on 23 February 2022).
- Schroder, K.; Battu, A.; Wentworth, L.; Houdek, J.; Fashanu, C.; Wiwa, O.; Kihoto, R.; Macharia, G.; Trikha, N.; Bahuguna, P.; et al. Increasing coverage of pediatric diarrhea treatment in high-burden countries. J. Glob. Health 2019, 9, 10503. [Google Scholar] [CrossRef] [PubMed]
- Strand, T.A.; Chandyo, R.K.; Bahl, R.; Sharma, P.R.; Adhikari, R.K.; Bhandari, N.; Ulvik, R.J.; Mølbak, K.; Bhan, M.K.; Sommerfelt, H. Effectiveness and efficacy of zinc for the treatment of acute diarrhea in young children. Pediatrics 2002, 109, 898–903. [Google Scholar] [CrossRef] [PubMed]
- National Population Commission Nigeria (NPC); ICF. Nigeria Demographic and Health Survey 2018; National Population Commission Nigeria (NPC): Abuja, Nigeria; ICF: Rockville, MD, USA, 2019. [Google Scholar]
- Zou, G. A modified Poisson regression approach to prospective studies with binary data. Am. J. Epidemiol. 2004, 159, 702–706. [Google Scholar] [CrossRef]
- StataCorp. Stata Statistical Software, Release 12; StataCorp LP: College Station, TX, USA, 2011. [Google Scholar]
- Apanga, P.A.; Kumbeni, M.T. Factors associated with diarrhea and acute respiratory infection in children under-5 years old in Ghana: An analysis of a national cross-sectional survey. BMC Pediatr. 2021, 21, 78. [Google Scholar] [CrossRef]
- Mulatyaa, D.M.; Ochieng, C. Disease burden and risk factors of diarrhoea in children under five years: Evidence from Kenya’s demographic health survey 2014. Int. J. Infect. Dis. 2020, 93, 359–366. [Google Scholar] [CrossRef]
- Omona, S.; Malinga, G.M.; Opoke, R.; Openy, G.; Opiyo, R. Prevalence of diarrhoea and associated risk factors among children under five years old in Pader District, northern Uganda. BMC Infect. Dis. 2020, 20, 37. [Google Scholar] [CrossRef]
- Frank, N.M.; Lynch, K.F.; Uusitalo, U.; Yang, J.; Lönnrot, M.; Virtanen, S.M.; Hyöty, H.; Norris, J.M. The relationship between breastfeeding and reported respiratory and gastrointestinal infection rates in young children. BMC Pediatr. 2019, 19, 339. [Google Scholar] [CrossRef]
- Kosek, M.; Bern, C.; Guerrant, R.L. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ. 2003, 8, 197–204. [Google Scholar]
- Ygberg, S.; Nilsson, A. The developing immune system—From foetus to toddler. Acta Paediatr. 2012, 101, 120–127. [Google Scholar] [CrossRef]
- Maggini, S.; Pierre, A.; Calder, P.C. Immune Function and Micronutrient Requirements Change over the Life Course. Nutrients 2018, 10, 1531. [Google Scholar] [CrossRef]
- Edwin, P.; Azage, M. Geographical Variations and Factors Associated with Childhood Diarrhea in Tanzania: A National Population Based Survey 2015–16. Ethiop. J. Health Sci. 2019, 29, 513–524. [Google Scholar] [CrossRef]
- Berde, A.S.; Yalçın, S.S.; Özcebe, H.; Üner, S.; Karadağ-Caman, Ö. Determinants of childhood diarrhea among under-five year old children in Nigeria: A population-based study using the 2013 demographic and health survey data. Turk. J. Pediatr. 2018, 60, 353–360. [Google Scholar] [CrossRef]
- Gebru, T.; Taha, M.; Kassahun, W. Risk factors of diarrhoeal disease in underfive children among health extension model and non-model families in Sheko district rural community, Southwest Ethiopia: Comparative cross-sectional study. BMC Public Health 2014, 14, 395. [Google Scholar] [CrossRef]
- Lam, F.; Abdulwahab, A.; Houdek, J.; Adekeye, O.; Abubakar, M.; Akinjeji, A.; Braimoh, T.; Ajeroh, O.; Stanley, M.; Goh, N.; et al. Program evaluation of an ORS and zinc scale-up program in 8 Nigerian states. J. Glob. Health 2019, 9, 10502. [Google Scholar] [CrossRef]
- Mohamed, S.O.O.; Alawad, M.O.A.; Ahmed, A.A.M.; Mahmoud, A.A.A. Access to oral rehydration solution and zinc supplementation for treatment of childhood diarrhoeal diseases in Sudan. BMC Res. Notes 2020, 13, 427. [Google Scholar] [CrossRef]
- Ebrahim, N.B.; Atteraya, M.S. Oral rehydration salts therapy use among children under five years of age with diarrhea in Ethiopia. J. Public Health Res. 2021, 10, 1732. [Google Scholar] [CrossRef] [PubMed]
- Yeshaw, Y.; Worku, M.G.; Tessema, Z.T.; Teshale, A.B.; Tesema, G.A. A Zinc utilization and associated factors among under-five children with diarrhea in East Africa: A generalized linear mixed modeling. PLoS ONE 2020, 15, e0243245. [Google Scholar] [CrossRef] [PubMed]
- Abolurin, O.O.; Olaleye, A.O.; Adekoya, A.O. Addressing the Sub-Optimal Use of Oral Rehydration Solution for Childhood Diarrhoea in the Tropics: Findings from a Rural Setting in Nigeria. J. Trop. Pediatr. 2020, 67, fmaa071. [Google Scholar] [CrossRef] [PubMed]
- Ogunrinde, O.G.; Raji, T.; Owolabi, O.A.; Anigo, K.M. Knowledge. Attitude and Practice of Home Management of Childhood Diarrhoea among Caregivers of Under-5 Children with Diarrhoeal Disease in Northwestern Nigeria. J. Trop. Pediatr. 2012, 58, 2. [Google Scholar] [CrossRef][Green Version]
- Olopha, O.O.; Egbewale, B. Awareness and Knowledge of Diarrhoeal Home Management among Mothers of Under-five in Ibadan, Nigeria. Univers. J. Public Health 2020, 5, 40–45. [Google Scholar] [CrossRef]
- Breastfeeding Frequently Asked Questions. Available online: https://www.cdc.gov/breastfeeding/faq/index.htm#howlong (accessed on 14 March 2022).
- Fewtrell, M.S.; Morgan, J.B.; Duggan, C.; Gunnlaugsson, G.; Hibberd, P.L.; Lucas, A.; Kleinman, R.E. Optimal duration of exclusive breastfeeding: What is the evidence to support current recommendations? Am. J. Clin. Nutr. 2007, 85, 635S–638S. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).